Antibiotics in pelvic infections.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D009175:Mycoplasma Infections / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000382:microbiology; D012488:Salpingitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy; D014384:Tuberculosis, Female Genital / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D013307:Streptomycin; D003091:Colistin